Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
0.800 | GeneticVariation | UNIPROT | |||||||
|
T | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
T | 0.700 | GeneticVariation | CLINVAR | ||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
A | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
CC | 0.700 | CausalMutation | CLINVAR | ||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
AGTC | 0.700 | GeneticVariation | CLINVAR | ||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
AGCATACGTGATG | 0.700 | CausalMutation | CLINVAR | ||||||
|
GTGTGGGCTC | 0.700 | CausalMutation | CLINVAR | ||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
0.700 | GeneticVariation | UNIPROT | |||||||
|
C | 0.700 | GeneticVariation | CLINVAR | Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. | 15737014 | 2005 |